AccScience Publishing / AN / Online First / DOI: 10.36922/AN026250026
Submit to AN
Cite this article
17
Download
128
Views
Journal Browser
Volume | Year
Issue
Search
Forthcoming Issue
Current Issue
View All
News and Announcements
View All
EDITORIAL

Neuroinflammation and neurodegeneration: Linking mechanisms, biomarkers, and therapeutic opportunity

Xinyang Zhang1,2 ,  Hio Lam Ho1,2 ,  Yuhong Fu3* ,  Zengqiang Yuan4* ,  Hong-Shuo Sun1,2,5,6*
Show Less
1 Department of Surgery, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
2 Department of Physiology, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
3 School of Medical Sciences, Faculty of Medicine and Health and the Brain and Mind Centre, University of Sydney, Camperdown, New South Wales, Australia
4 Hengyang Medical School, University of South China, Hengyang, Hunan, China
5 Department of Pharmacology and Toxicology, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
6 Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada
Advanced Neurology, 026250026 https://doi.org/10.36922/AN026250026
Received: 18 June 2026 | Published online: 20 July 2026
© 2026 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )
Download PDF
XML
Cite
Funding
This work was financially supported by the following grants: Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grants (RGPIN-2022-04589) and Heart and Stroke Foundation of Canada (HSFC) grant (G-23-0035032) to HSS; Ontario Graduate Scholarship International (OGS-PhD Int), Heart & Stroke/Richard Lewar Centre of Excellence in Cardiovascular Research (HSRLCE) Studentship Award, and China Scholarship Council (CSC) Doctoral Scholarship to XZ.
Conflict of interest
Yuhong Fu, Zengqiang Yuan, and Hong-Shuo Sun serve as Editorial Board Members of this journal. All authors declare that they have no known competing financial interests or personal relationships that could have influenced the work reported in this paper.
References
  1. Heneka MT, Carson MJ, El Khoury J, et al. Neuroinflammation in Alzheimer’s disease. Lancet Neurol. 2015;14(4):388-405. doi: 10.1016/S1474-4422(15)70016-5
  2. Ransohoff, RM. How neuroinflammation contributes to neurodegeneration. Science. 2016;353(6301):777-783. doi: 10.1126/science.aag2590
  3. Zhang XY, Ho HL, Feng ZP, Sun HS. TRPM7 kinase: a target for multimodal drug development in neurological disorders. Acta Pharmacol Sin. 2026. doi: 10.1038/s41401-026-01810-z
  4. Escartin C, Galea E, Lakatos A, et al. Reactive astrocyte nomenclature, definitions, and future directions. Nat Neurosci. 2021;24(3):312-325. doi: 10.1038/s41593-020-00783-4
  5. Hickman S, Izzy S, Sen P, Morsett L, El Khoury J. Microglia in neurodegeneration. Nat Neurosci. 2018;21(10):1359-1369. doi: 10.1038/s41593-018-0242-x
  6. Tansey MG, Wallings RL, Houser MC, Herrick MK, Keating CE, Joers V. Inflammation and immune dysfunction in Parkinson disease. Nat Rev Immunol. 2022;22(11):657-673. doi: 10.1038/s41577-022-00684-6
  7. Rifai OM, O’Shaughnessy J, Dando OR, et al. Distinct neuroinflammatory signatures exist across genetic and sporadic amyotrophic lateral sclerosis cohorts. Brain. 2023;146(12):5124-5138. doi: 10.1093/brain/awad243
  8. Iadecola C, Anrather J. The immunology of stroke: from mechanisms to translation. Nat Med. 2011;17(7):796-808. doi: 10.1038/nm.2399
  9. Iadecola C. The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease. Neuron. 2017;96(1):17-42. doi: 10.1016/j.neuron.2017.07.030
  10. Sweeney MD, Sagare AP, Zlokovic BV. Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol. 2018;14(3):133-150. doi: 10.1038/nrneurol.2017.188
  11. Swanson KV, Deng M, Ting JP. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol. 2019;19(8):477-489. doi: 10.1038/s41577-019-0165-0
  12. Gate D, Saligrama N, Leventhal O, et al. Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer’s disease. Nature. 2020;577(7790):399-404. doi: 10.1038/s41586-019-1895-7
  13. Young AL, Marinescu RV, Oxtoby NP, et al. Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference. Nat Commun. 2018;9(1):4273. doi: 10.1038/s41467-018-05892-0
  14. Iturria-Medina Y, Sotero RC, Toussaint PJ, Mateos-Pérez JM, Evans AC; Alzheimer’s Disease Neuroimaging Initiative. Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis. Nat Commun. 2016;7:11934. doi: 10.1038/ncomms11934
  15. Hampel H, O’Bryant SE, Molinuevo JL, et al. Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic. Nat Rev Neurol. 2018;14(11):639-652. doi: 10.1038/s41582-018-0079-7
  16. Pascoal TA, Benedet AL, Ashton NJ, et al. Microglial activation and tau propagate jointly across Braak stages. Nat Med. 2021;27(9):1592-1599. doi: 10.1038/s41591-021-01456-w
  17. Marx V. Method of the Year: spatially resolved transcriptomics. Nat Methods. 2021;18(1):9-14. doi: 10.1038/s41592-020-01033-y.
  18. Hammond TR, Dufort C, Dissing-Olesen L, et al. Single-Cell RNA Sequencing of Microglia throughout the Mouse Lifespan and in the Injured Brain Reveals Complex Cell-State Changes. Immunity. 2019;50(1):253-271.e6. doi: 10.1016/j.immuni.2018.11.004
  19. Masuda T, Sankowski R, Staszewski O, et al. Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution. Nature. 2019;566(7744):388-392. doi: 10.1038/s41586-019-0924-x
  20. Zhang XY, Ho HL, Luo ZW, et al. TRPM7 kinase inhibitor TG100-115 provides neuroprotection against neonatal hypoxic-ischemic brain injury. Acta Pharmacol Sin. doi: 10.1038/s41401-026-01775-z
  21. Zhang XY, Ho HL, Feng ZP, Sun HS. Neuroprotective Effects of Carvacrol in Cerebral Ischemia and Hypoxia. IJDDP. 2026;5(1):100003. doi: 10.53941/ijddp.2026.100003
  22. Ferreira AFF, Feng ZP, Sun HS, Britto LRG. Microglial Activation and Inflammatory Responses in Parkinson’s Disease Models Are Attenuated by TRPM2 Depletion. Glia. 2025;73(10):2035-2056. doi: 10.1002/glia.70055
  23. Pan N, Lu LY, Li M, et al. Xyloketal B alleviates cerebral infarction and neurologic deficits in a mouse stroke model by suppressing the ROS/TLR4/NF-κB inflammatory signaling pathway. Acta Pharmacol Sin. 2017;38(9):1236-1247. doi: 10.1038/aps.2017.22
  24. Li Q, Barres BA. Microglia and macrophages in brain homeostasis and disease. Nat Rev Immunol. 2018;18(4):225-242. doi: 10.1038/nri.2017.125
Next article in this issue
Share
Back to top
Advanced Neurology, Electronic ISSN: 2810-9619 Print ISSN: 3060-8589, Published by AccScience Publishing
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here
Accept